438 related articles for article (PubMed ID: 22826346)
1. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists.
Duman RS; Li N
Philos Trans R Soc Lond B Biol Sci; 2012 Sep; 367(1601):2475-84. PubMed ID: 22826346
[TBL] [Abstract][Full Text] [Related]
2. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Li N; Lee B; Liu RJ; Banasr M; Dwyer JM; Iwata M; Li XY; Aghajanian G; Duman RS
Science; 2010 Aug; 329(5994):959-64. PubMed ID: 20724638
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways underlying the rapid antidepressant actions of ketamine.
Duman RS; Li N; Liu RJ; Duric V; Aghajanian G
Neuropharmacology; 2012 Jan; 62(1):35-41. PubMed ID: 21907221
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
Deyama S; Duman RS
Pharmacol Biochem Behav; 2020 Jan; 188():172837. PubMed ID: 31830487
[TBL] [Abstract][Full Text] [Related]
5. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.
Liu RJ; Lee FS; Li XY; Bambico F; Duman RS; Aghajanian GK
Biol Psychiatry; 2012 Jun; 71(11):996-1005. PubMed ID: 22036038
[TBL] [Abstract][Full Text] [Related]
7. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
Li N; Liu RJ; Dwyer JM; Banasr M; Lee B; Son H; Li XY; Aghajanian G; Duman RS
Biol Psychiatry; 2011 Apr; 69(8):754-61. PubMed ID: 21292242
[TBL] [Abstract][Full Text] [Related]
8. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.
Voleti B; Navarria A; Liu RJ; Banasr M; Li N; Terwilliger R; Sanacora G; Eid T; Aghajanian G; Duman RS
Biol Psychiatry; 2013 Nov; 74(10):742-9. PubMed ID: 23751205
[TBL] [Abstract][Full Text] [Related]
9. Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine.
Deyama S; Kaneda K
Neuropharmacology; 2023 Feb; 224():109335. PubMed ID: 36403852
[TBL] [Abstract][Full Text] [Related]
10. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K
Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718
[TBL] [Abstract][Full Text] [Related]
11. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Autry AE; Adachi M; Nosyreva E; Na ES; Los MF; Cheng PF; Kavalali ET; Monteggia LM
Nature; 2011 Jun; 475(7354):91-5. PubMed ID: 21677641
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.
Duman RS
Dialogues Clin Neurosci; 2014 Mar; 16(1):11-27. PubMed ID: 24733968
[TBL] [Abstract][Full Text] [Related]
13. Spine synapse remodeling in the pathophysiology and treatment of depression.
Duman CH; Duman RS
Neurosci Lett; 2015 Aug; 601():20-9. PubMed ID: 25582786
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR.
Akinfiresoye L; Tizabi Y
Psychopharmacology (Berl); 2013 Nov; 230(2):291-8. PubMed ID: 23732839
[TBL] [Abstract][Full Text] [Related]
15. NMDA antagonist treatment of depression.
Williams NR; Schatzberg AF
Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375
[TBL] [Abstract][Full Text] [Related]
16. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
[TBL] [Abstract][Full Text] [Related]
17. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
18. Potential link between antidepressant-like effects of ketamine and promotion of adult neurogenesis in the ventral hippocampus of mice.
Yamada J; Jinno S
Neuropharmacology; 2019 Nov; 158():107710. PubMed ID: 31310776
[TBL] [Abstract][Full Text] [Related]
19. Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function.
Duman RS; Shinohara R; Fogaça MV; Hare B
Mol Psychiatry; 2019 Dec; 24(12):1816-1832. PubMed ID: 30894661
[TBL] [Abstract][Full Text] [Related]
20. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
